The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXPD.L Regulatory News (XPD)

  • There is currently no data for XPD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Xpediator Plc

30 Jun 2023 12:58

Samson Rock Capital LLP - Form 8.3 - Xpediator Plc

Samson Rock Capital LLP - Form 8.3 - Xpediator Plc

PR Newswire

London, June 30

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:SAMSON ROCK CAPITAL LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeXPEDIATOR PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 29/06/2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Ordinary 5p
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:11,600,2458.19
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:11,600,2458.19

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
5p OrdinaryPURCHASE280,00043.52 GBp

 (b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:30/06/2023
Contact name:Abel Romero
Telephone number*:02039941800

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
4th Jan 20236:20 pmRNSForm 8.3 - Xpediator plc
4th Jan 20233:14 pmRNSForm 8 (OPD) - Xpediator plc
21st Dec 202210:29 amRNSForm 8.3 - Xpediator plc
20th Dec 202211:05 amRNSSecond Price Monitoring Extn
20th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20229:41 amRNSForm 8.3 - Xpediator plc
20th Dec 20227:00 amRNSAnnouncement regarding possible offer
3rd Nov 20227:00 amRNSQ3 Trading Update
27th Sep 20229:05 amRNSSecond Price Monitoring Extn
27th Sep 20229:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSHalf-year Report
20th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
10th Jun 202212:56 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
1st Jun 20227:00 amRNSBoard updates
17th May 20228:15 amRNSNotice of AGM
17th May 20227:00 amRNSDirectorate Change
4th Apr 20227:00 amRNSFinal Results
28th Mar 20227:00 amRNSNotice of Results
25th Mar 20224:17 pmRNSDirectorate Change
31st Jan 20227:00 amRNSTrading Update
19th Jan 20227:00 amRNSChange of Adviser
17th Jan 20227:00 amRNSNew Warehouse
22nd Nov 20211:00 pmRNSDirectorate Change
13th Sep 20217:00 amRNSInterim Results
8th Sep 20217:00 amRNSNotice of Results
6th Aug 20217:00 amRNSStrategic Partnership
6th Jul 20217:00 amRNSExercise of Warrants
25th Jun 20217:00 amRNSTrading Statement
8th Jun 20213:30 pmRNSResult of AGM
8th Jun 20217:00 amRNSAGM Statement
25th May 20217:00 amRNSUpdated Ex-Dividend and Record Dates
12th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
12th Apr 20217:00 amRNSFinal Results
7th Apr 20217:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 202111:05 amRNSSecond Price Monitoring Extn
19th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSLaunch of CSOP and Issue of awards to Director
29th Jan 202111:06 amRNSSecond Price Monitoring Extn
29th Jan 202111:00 amRNSPrice Monitoring Extension
29th Jan 20217:00 amRNSTrading Statement
19th Jan 20217:00 amRNSDirectorate Change
31st Dec 20207:00 amRNSDisposal
1st Dec 20207:00 amRNSInvestor Presentation
23rd Nov 20207:00 amRNSTrading Statement
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
6th Oct 20207:00 amRNSAcquisition
1st Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.